» Articles » PMID: 10957931

Recent Developments in Chest Pain of Undetermined Origin

Overview
Specialty Gastroenterology
Date 2000 Aug 25
PMID 10957931
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The syndrome of angina-like pain with normal epicardial coronary vessels is a very common and expensive clinical problem. Patients suffering from this condition frequently present a diagnostic challenge. Cardiac and musculoskeletal disorders must be excluded prior to identifying the esophagus as the source of pain. The term "chest pain of undetermined origin" (UCP) has been proposed to refer to this condition. Esophageal dysmotility was previously considered a major source for chest pain; however, recent studies indicate that esophageal reflux is the most common cause of esophageal pain. Two controlled trials of acid suppressive agents in patients with chest pain have shown that omeprazole provides effective pain relief for the majority of these individuals. Visceral hyperalgesia and psychologic disturbances are also commonly noted in patients with UCP. Much remains to be learned about the etiology of visceral hyperalgesia and the precise role of psychologic abnormalities in these patients. Until further information is available, treatment with imipramine or trazodone has been shown to offer effective relief of chest pain for subgroups of patients with UCP. Psychologic intervention is also valuable in the management of some patients. Studies of other therapeutic regimens continue to be conducted.

Citing Articles

Diagnostic indicators of non-cardiovascular chest pain: a systematic review and meta-analysis.

Wertli M, Ruchti K, Steurer J, Held U BMC Med. 2013; 11:239.

PMID: 24207111 PMC: 4226211. DOI: 10.1186/1741-7015-11-239.


Diagnostic utility of the oesophageal balloon distension test in the evaluation of oesophageal chest pain.

Nasr I, Attaluri A, Coss-Adame E, Rao S Aliment Pharmacol Ther. 2012; 35(12):1474-81.

PMID: 22524415 PMC: 4470272. DOI: 10.1111/j.1365-2036.2012.05103.x.


Recent advances in noncardiac chest pain in Korea.

Kim J, Rhee P Gut Liver. 2012; 6(1):1-9.

PMID: 22375165 PMC: 3286725. DOI: 10.5009/gnl.2012.6.1.1.


Management of esophageal chest pain.

Achem S Gastroenterol Hepatol (N Y). 2011; 3(10):765-7.

PMID: 21960783 PMC: 3104155.


The hypersensitive esophagus: pathophysiology, evaluation, and treatment options.

Remes-Troche J Curr Gastroenterol Rep. 2010; 12(5):417-26.

PMID: 20669058 DOI: 10.1007/s11894-010-0122-3.


References
1.
DeVault K, Beacham S, Castell D, Streletz L, Ditunno J . Esophageal sensation in spinal cord-injured patients: balloon distension and cerebral evoked potential recording. Am J Physiol. 1996; 271(6 Pt 1):G937-41. DOI: 10.1152/ajpgi.1996.271.6.G937. View

2.
Savage D, Devereux R, Garrison R, CASTELLI W, Anderson S, Levy D . Mitral valve prolapse in the general population. 2. Clinical features: the Framingham Study. Am Heart J. 1983; 106(3):577-81. DOI: 10.1016/0002-8703(83)90705-6. View

3.
Rao S, Gregersen H, Hayek B, Summers R, Christensen J . Unexplained chest pain: the hypersensitive, hyperreactive, and poorly compliant esophagus. Ann Intern Med. 1996; 124(11):950-8. DOI: 10.7326/0003-4819-124-11-199606010-00002. View

4.
Richter J, Bradley L, Castell D . Esophageal chest pain: current controversies in pathogenesis, diagnosis, and therapy. Ann Intern Med. 1989; 110(1):66-78. DOI: 10.7326/0003-4819-110-1-66. View

5.
Peghini P, Katz P, Bracy N, Castell D . Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol. 1998; 93(5):763-7. DOI: 10.1111/j.1572-0241.1998.221_a.x. View